Madhumeeta joined the lab in 2024 after earning her Ph.D. in Cancer Biology from the Institute of Cancer Research, London. Her research focuses on multi-omics molecular profiling, leveraging proteomics and transcriptomics to identify and validate clinically relevant therapeutic biomarkers and targets, particularly in retinal diseases. She also applies advanced bioinformatics methodologies to support data-driven translational research.